Xie, Z., Mo, Q., Buckley, S., Sallman, D., Lancet, J., Savona, M., Komrokji, R., Patnaik, M., Wiseman, D., Padron, E. (2025). Prospera (ABNL-MARRO 002): A randomized phase 2 study of pacritinib vs. hydroxyurea in patients with advanced proliferative chronic myelomonocytic leukemia (CMML). Blood. https://doi.org/10.1182/blood-2025-3873